Delivery Order SPE2DR25D3103-SPE2DR26F9M21
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,332.89 for Methylphenidate ER 54 mg tablets (100-count bottles) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military and healthcare systems. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.57 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) with a completion deadline of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) under a firm fixed-price contract with a ceiling value of $1,431.52. This is a non-set-aside competitive award, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,918.35 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count units). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 24, 2025. The award was made on September 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,474.45 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count packaging). This non-competitive, firm fixed-price delivery order was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price contract valued at $2,059.92. The award, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a competitive non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count units) with a ceiling value of $1,533.28. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) valued at $1,269.30. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by November 7, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.20 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Methylphenidate ER 54 mg tablets in quantities of 100 units. This contract employs firm fixed price terms with an ultimate completion date of July 15, 2025, and is classified as a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9M21Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,079.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count packaging). This competitive, non-set-aside contract employs firm fixed pricing and was awarded on December 5, 2025, with an ultimate completion date of December 8, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support globally, enabling the delivery of a wide range of medications, vaccines, and medical supplies to support military healthcare operations. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of contract awards with DLA for various therapeutic categories supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/4/25 |